Trial Profile
nilotinib pharmacokinetics correlation with clinical response and adverse events in chronic myelogenous leukemia.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 30 Jun 2021
Price :
$35
*
At a glance
- Drugs Nilotinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Pharmacokinetics
- 15 Dec 2009 New trial record